Evidence map›Paper›PMID 33025479›Full record

ArticleJournal of molecular neuroscience : MN2021

Functional Analysis of a Compound Heterozygous Mutation in the VPS13B Gene in a Chinese Pedigree with Cohen Syndrome.

Guiyu Lou, Yang Ke, Yuwei Zhang, Guo Liangjie, Samaa Abdelmonem Shama, Na Qi, Litao Qin, Shixiu Liao, Yuanyin Zhao

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. A Novel Variant inBioMed research international · 2023
    Article
  3. A Novel HomozygousFrontiers in pediatrics · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Guiyu LouMedical Genetics Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou, 450003, China.ORCID http://orcid.org/0000-0001-5549-4659
Yang KeMedical Genetics Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou, 450003, China.
Yuwei ZhangMedical Genetics Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou, 450003, China.
Guo LiangjieMedical Genetics Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou, 450003, China.
Samaa Abdelmonem ShamaNational Organization for Drug Control and Research, Governorate, Giza, Egypt.
Na QiMedical Genetics Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou, 450003, China.
Litao QinMedical Genetics Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou, 450003, China.
Shixiu LiaoMedical Genetics Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou, 450003, China. ychslshx@126.com.
Yuanyin ZhaoDepartment of Biochemistry and Molecular Biology, College of Basic Medical Science, Army Medical University, No. 30 Gaotanyan Street, Chongqing, 400038, China. yuanyinzhao@foxmail.com.
Henan University · CNArmy Medical University · CNNational Organization for Drug Control and Research · EG

Funding

Natural Science Foundation of Henan Province 172102310296Young Scientists Fund 31401103
6 · The paper itself

Abstract

Cohen syndrome (CS) is an autosomal recessive congenital disorder characterized by mutation in the vacuolar protein sorting 13 homolog B (VPS13B; formerly COH1) gene. In the current study, a Chinese family has two young sibling cases having a developmental delay, physical obesity, high myopia, and a special face, which suspected to be CS. The purpose of the study was to identify variants and further analyze their pathogenicity for CS. Next-generation sequencing (NGS) revealed a compound heterozygous mutation in VPS13B gene in the proband, which comprises a frameshift mutation in NM_017890.4: c.10076_10077delCA (p.T3359fs*29) and a putative splice site mutation in c.6940 + 1G > T. Both Minigene assay in vitro and splicing assay in vivo confirmed that the splicing mutation in c.6940 + 1G > T generates a frameshift transcript with whole exon 38 skipping. Eventually, quantitative real-time PCR demonstrated that either of the two mutations can lead to degradation of the VPS13B gene at the transcriptional level. Functional studies of variants identified in CS patients are essential for their subsequent genetic counseling and prenatal diagnoses and could also be the start point for new therapeutic approaches, currently based only on symptomatic treatment.

Indexed as

ChildChild, PreschoolDevelopmental DisabilitiesFemaleFingersFrameshift MutationHeterozygoteHumansIntellectual DisabilityMicrocephalyMuscle HypotoniaMyopiaObesityPedigreePhenotypeRetinal DegenerationVesicular Transport ProteinsVPS13B protein, humanCohen syndromeFunctional analysisMutationPedigreeVPS13B gene

Identifiers

PMID33025479
OpenAlexW3092149042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.